New imaging methods for the detection of cancer biomarkers

Lead Research Organisation: University College London
Department Name: Electronic and Electrical Engineering

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications

10 25 50
 
Description Developed novel techniques for electrical impedance imaging.
Exploitation Route To develop technology for cancer diagnostics of the colorectum.
Sectors Electronics,Healthcare

 
Description Impact Acceleration Account (D2U) - UCL/EPSRC (Part 1)
Amount £48,000 (GBP)
Funding ID G.1.8 
Organisation University College London 
Sector Academic/University
Country United Kingdom
Start 01/2014 
End 07/2015
 
Description Impact Acceleration Account (D2U) - UCL/EPSRC (Part 2)
Amount £49,000 (GBP)
Funding ID G.2.5 
Organisation University College London 
Sector Academic/University
Country United Kingdom
Start 01/2016 
End 12/2016
 
Description GOSH 
Organisation Great Ormond Street Hospital (GOSH)
Country United Kingdom 
Sector Hospitals 
PI Contribution We provided expertise in bioimpedance measurements for clinical applications.
Collaborator Contribution They provided expertise in neonatal lung function.
Impact N/A
Start Year 2006
 
Description Zilico Ltd 
Organisation Zilico Ltd
Country United Kingdom 
Sector Private 
PI Contribution We provided expertise in microelectronics for bioimpedance measurement instrumentation - we are working with them to develop a 'platform' technology for future products.
Collaborator Contribution They provided access to their products which we have been using for our clinical measurements in colorectal cancer.
Impact N/A
Start Year 2010
 
Title DETECTION OF CANCER 
Description The use of nanoparticles for imaging a tumour in a mammal using electrical impedance tomography. The nanoparticles comprise a core of metal and/or semiconductor atoms to which are linked ligands that comprise a molecule capable of attaching to a specific tumour biomarker. 
IP Reference US2011212029 
Protection Patent granted
Year Protection Granted 2011
Licensed No
Impact New method for detecting cancer tumour regions.